NCT05365581 2026-02-13
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Astellas Pharma Inc
Phase 1 Recruiting
Clinical Trials
19 trialsNCT05273554 2026-01-12
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04361708 2025-10-01
I-FLOAT
University of Chicago
Phase 1 Recruiting
NCT04627246 2025-02-25
Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer
Centre Hospitalier Universitaire Vaudois
Phase 1 Active not recruiting
NCT01010945 2024-11-21
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
Astellas Pharma Inc
Phase 1 Completed
NCT04086758 2024-11-20
A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Inc
Phase 1 Completed
NCT01579994 2020-12-30
Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT04315155 2020-10-28
BENEFIT
University of Utah
Phase 1 Withdrawn
NCT01342224 2018-04-12
Immunochemoradiotherapy in Patients With Pancreatic Cancer
Providence Health & Services
Phase 1 Completed
NCT00499850 2016-08-25
Phase I FOLFOX Combination
Sanofi
Phase 1 Completed
NCT00507091 2016-08-25
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
Sanofi
Phase 1 Completed
NCT01778920 2016-05-17
Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)
University of Pennsylvania
Phase 1 Completed
NCT01674556 2015-09-24
Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer
Haukeland University Hospital
Phase 1 Completed
NCT00892242 2014-09-22
Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT02204046 2014-07-30
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast
Boehringer Ingelheim
Phase 1 Completed
NCT01253525 2014-06-18
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas
Eli Lilly and Company
Phase 1 Completed
NCT00292864 2012-06-07
Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
Sunesis Pharmaceuticals
Phase 1 Completed
NCT00298545 2011-11-18
Effect of Vitamin D and Calcium on Genes in the Colon
Rockefeller University
Phase 1 Completed
NCT00051675 2005-06-24
Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas
XOMA (US) LLC
Phase 1 Completed